The PEERLESS II Study

NCT06055920 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Embolism

Interventions

DEVICE: FlowTriever System
DRUG: Anticoagulation Agents

Sponsor

Inari Medical